PMC:7473770 / 32835-33427 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T227","span":{"begin":244,"end":252},"obj":"Body_part"}],"attributes":[{"id":"A227","pred":"fma_id","subj":"T227","obj":"http://purl.org/sig/ont/fma/fma264783"}],"text":"Table 2. Sample and medical information.\nAge and gender, clinical presentation with hospitalization and treatment; NIV: non-invasive ventilation, I: immunosuppression, S: smoker, GGO: ground-glass opacification, C: consolidation, DAD: diffuse alveolar damage.\nSample no. Age group, gender Hospitalization, clinical, radiological, and histological characteristics\nI 60–70, F 5-10d, GGO, DAD\nII 80–90, M 5-10d, C, I, DAD\nIII 90–100, M 1-4d, GGO, C, DAD\nIV 70–80, M 1-4d, NIV, S, GGO, C, DAD\nV 60–70, M 5-10d, NIV, S, GGO, C, DAD\nVI 70–80, M 1-4d, S, GGO, C, DAD\nCTRL 20–30, M -"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T327","span":{"begin":376,"end":380},"obj":"http://purl.obolibrary.org/obo/CLO_0002983"},{"id":"T328","span":{"begin":439,"end":443},"obj":"http://purl.obolibrary.org/obo/CLO_0007437"},{"id":"T329","span":{"begin":471,"end":475},"obj":"http://purl.obolibrary.org/obo/CLO_0007437"},{"id":"T330","span":{"begin":551,"end":555},"obj":"http://purl.obolibrary.org/obo/CLO_0007437"}],"text":"Table 2. Sample and medical information.\nAge and gender, clinical presentation with hospitalization and treatment; NIV: non-invasive ventilation, I: immunosuppression, S: smoker, GGO: ground-glass opacification, C: consolidation, DAD: diffuse alveolar damage.\nSample no. Age group, gender Hospitalization, clinical, radiological, and histological characteristics\nI 60–70, F 5-10d, GGO, DAD\nII 80–90, M 5-10d, C, I, DAD\nIII 90–100, M 1-4d, GGO, C, DAD\nIV 70–80, M 1-4d, NIV, S, GGO, C, DAD\nV 60–70, M 5-10d, NIV, S, GGO, C, DAD\nVI 70–80, M 1-4d, S, GGO, C, DAD\nCTRL 20–30, M -"}

{"project":"LitCovid-sentences","denotations":[{"id":"T249","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T250","span":{"begin":10,"end":41},"obj":"Sentence"},{"id":"T251","span":{"begin":42,"end":260},"obj":"Sentence"},{"id":"T252","span":{"begin":261,"end":271},"obj":"Sentence"},{"id":"T253","span":{"begin":273,"end":365},"obj":"Sentence"},{"id":"T254","span":{"begin":366,"end":394},"obj":"Sentence"},{"id":"T255","span":{"begin":395,"end":425},"obj":"Sentence"},{"id":"T256","span":{"begin":426,"end":459},"obj":"Sentence"},{"id":"T257","span":{"begin":460,"end":499},"obj":"Sentence"},{"id":"T258","span":{"begin":500,"end":539},"obj":"Sentence"},{"id":"T259","span":{"begin":540,"end":574},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 2. Sample and medical information.\nAge and gender, clinical presentation with hospitalization and treatment; NIV: non-invasive ventilation, I: immunosuppression, S: smoker, GGO: ground-glass opacification, C: consolidation, DAD: diffuse alveolar damage.\nSample no. Age group, gender Hospitalization, clinical, radiological, and histological characteristics\nI 60–70, F 5-10d, GGO, DAD\nII 80–90, M 5-10d, C, I, DAD\nIII 90–100, M 1-4d, GGO, C, DAD\nIV 70–80, M 1-4d, NIV, S, GGO, C, DAD\nV 60–70, M 5-10d, NIV, S, GGO, C, DAD\nVI 70–80, M 1-4d, S, GGO, C, DAD\nCTRL 20–30, M -"}

{"project":"LitCovid-PubTator","denotations":[{"id":"287","span":{"begin":244,"end":259},"obj":"Disease"}],"attributes":[{"id":"A287","pred":"tao:has_database_id","subj":"287","obj":"MESH:D055370"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 2. Sample and medical information.\nAge and gender, clinical presentation with hospitalization and treatment; NIV: non-invasive ventilation, I: immunosuppression, S: smoker, GGO: ground-glass opacification, C: consolidation, DAD: diffuse alveolar damage.\nSample no. Age group, gender Hospitalization, clinical, radiological, and histological characteristics\nI 60–70, F 5-10d, GGO, DAD\nII 80–90, M 5-10d, C, I, DAD\nIII 90–100, M 1-4d, GGO, C, DAD\nIV 70–80, M 1-4d, NIV, S, GGO, C, DAD\nV 60–70, M 5-10d, NIV, S, GGO, C, DAD\nVI 70–80, M 1-4d, S, GGO, C, DAD\nCTRL 20–30, M -"}